Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women
Sponsored by GOG Foundation, Inc.
Active
$270.2K Funding
6 People
External
Related Topics
clinical trials,
cancer treatment,
immunotherapy,
chemotherapy,
women's health
People
Aradhana Kari
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Angelique Thornton
(CD)
Cancer Center Division
﹒Research Nurse II
Mitzi Miranda
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology
﹒Professor
Carolyn Lane
(CD)
Cancer Center Division
﹒Research Laboratory Manager I
Sonja Velickovic
(CD)
Cancer Center Division
﹒Laboratory Coordinator I
